PHD1 Antikörper (N-Term)
Kurzübersicht für PHD1 Antikörper (N-Term) (ABIN927491)
Target
Alle PHD1 (EGLN2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Hund
-
Aufreinigung
- Purified
-
Immunogen
- EGLN2 antibody was raised in rabbit using the N terminal of EGLN2 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
EGLN2 Blocking Peptide, (ABIN5613318), is also available for use as a blocking control in assays to test for specificity of this EGLN2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PHD1 (EGLN2) (Egl-9 Family Hypoxia Inducible Factor 2 (EGLN2))
-
Andere Bezeichnung
- EGLN2
-
Hintergrund
- The hypoxia inducible factor (HIF) is a transcriptional complex which is involved in oxygen homeostasis. At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation. EGLN2 encodes an enzyme responsible for this posttranslational modification. Alternative splicing of EGLN2 results in three transcript variants encoding different isoforms. Synonyms: Polyclonal EGLN2 antibody, Anti-EGLN2 antibody, egl nine homolog 2, C. elegans antibody.
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Cell RedoxHomeostasis
Target
-